ATE242212T1 - Benz(f)indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen - Google Patents

Benz(f)indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen

Info

Publication number
ATE242212T1
ATE242212T1 AT00987215T AT00987215T ATE242212T1 AT E242212 T1 ATE242212 T1 AT E242212T1 AT 00987215 T AT00987215 T AT 00987215T AT 00987215 T AT00987215 T AT 00987215T AT E242212 T1 ATE242212 T1 AT E242212T1
Authority
AT
Austria
Prior art keywords
treatment
benz
indole
related disorders
receptor related
Prior art date
Application number
AT00987215T
Other languages
English (en)
Inventor
Laramie Mary Gaster
Thomas Daniel Heightman
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE242212T1 publication Critical patent/ATE242212T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00987215T 1999-11-05 2000-11-02 Benz(f)indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen ATE242212T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9926301.4A GB9926301D0 (en) 1999-11-05 1999-11-05 Novel compounds
PCT/EP2000/010913 WO2001032647A2 (en) 1999-11-05 2000-11-02 Benz`f!indoles for use in the treatment of 5ht receptor related disorders

Publications (1)

Publication Number Publication Date
ATE242212T1 true ATE242212T1 (de) 2003-06-15

Family

ID=10864070

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00987215T ATE242212T1 (de) 1999-11-05 2000-11-02 Benz(f)indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen

Country Status (7)

Country Link
EP (1) EP1226120B1 (de)
JP (1) JP2003513086A (de)
AT (1) ATE242212T1 (de)
DE (1) DE60003214T2 (de)
ES (1) ES2199888T3 (de)
GB (1) GB9926301D0 (de)
WO (1) WO2001032647A2 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201403T1 (de) * 1993-03-16 2001-06-15 Pfizer Naphtalinderivate

Also Published As

Publication number Publication date
DE60003214D1 (de) 2003-07-10
WO2001032647A2 (en) 2001-05-10
EP1226120B1 (de) 2003-06-04
ES2199888T3 (es) 2004-03-01
JP2003513086A (ja) 2003-04-08
EP1226120A2 (de) 2002-07-31
GB9926301D0 (en) 2000-01-12
DE60003214T2 (de) 2004-04-29
WO2001032647A3 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
CY1113306T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
ATE370139T1 (de) Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs
ECSP941122A (es) Derivados de 5-arilindoles
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
ATE396722T1 (de) Kleine moleküle zur behandlung von endzündlichen erkrankungen
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
BG101806A (bg) Индолови производни като антагонисти на 5-нт рецептори
TR200003206T2 (tr) İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları.
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DK1458713T3 (da) Indolinonderivater anvendelige som proteinkinaseinhibitorer
NO20044764L (no) 1-(aminoalkyl)-3-sulfonylindol og -indazolderivater som 5-hydroksytryptamin-6 ligander
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
ATE364044T1 (de) 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit
DE60001586D1 (de) Diphenyl-piperidin derivate
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ATE255094T1 (de) Piperazinderivate zur behandlung der niedrigen harnwege
ATE267816T1 (de) Tan-1057 derivate
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
DE69937692D1 (de) Arzneimittel zur behandlung der hemicrania
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE306483T1 (de) Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung
BRPI0410026A (pt) derivados de 3-amino-croman quinolina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties